In today's weekly Exponential Investor podcast, we talk about the biggest question you will face in recent times… to jab or not to jab?
|
|
| Sam Volkering & Kit Winder | 04 Dec 2020 |
Podcast: to jab or not to jab?
In today's Exponential Investor…
- It's time to decide
- Optimism or mistrust?
- Perhaps this is the next medical frontier
In today's weekly Exponential Investor podcast, we talk about the biggest question you will face in recent times… to jab or not to jab?
We're not talking about an exhibition bout between Mike Tyson and Roy Jones Jr. We're talking about the Covid-19 vaccination.
If one were to rock up on your doorstep tomorrow, do you take the jab or not?
We're both confident that taking it isn't going to inject us with a trackable microchip. If anyone wanted to track you, it's pretty damn easy to without having to sneak a chip into your bloodstream with a vaccine.
Take it or don't, that choice is yours and yours alone and we certainly won't judge you for whatever you decide. However, we would suggest that perhaps we should take a moment to consider over the last 100 years the progress that medicine and medical therapies have achieved.
While there's a lot of mistrust, distrust, lack of trust in the world, there's also a good reason why people live longer, are healthier and increasingly have access to better medical care. And that's 100-plus years of progress.
Sure it's not perfect, and not all healthcare systems are fit for purpose, but there is some optimism to be taken out from all this and the ability for medicine and biotechnology to unify, mobilise and solve a pressing, urgent need.
We also briefly touch on the UN making an announcement overnight about another form of medical therapy that could very well become the next frontier of medical progress.
It's an area of medicine we've been looking at for some time, and now it appears we just might (once again) be at an inflection point of opportunity for what comes next.
All that and more in today's Exponential Investor podcast, which you can access here.
Regards,
 
Sam Volkering and Kit Winder
Exponential Investor
You may be interested inBetter than 2 for 1 – by HALF!
My name is Paolo Cabrelli and I am the publisher here at Southbank Investment Research.
And I am here to make you the best introductory offer I have ever made…
The Fleet Street Letter Monthly Alert and Frontier Tech Investor are two of my flagship investment advisories. They are popular for helping investors understand the bigger picture – and providing them with specific opportunities to potentially protect and grow their wealth.
Here's what readers of both have said:
"I don't think anyone does a better job. Clear, concise information that is not published anywhere else." –JS
"As interesting as it is profitable." – GB
As you have yet to try our work, I'd like to offer you both – at an extremely generous discount.
Initially it was going to be two for the price of the less expensive one.
Except I have decided to HALVE that as well… and throw in two FREE bonus gifts as well.
If you'd like to take me up on it, please click here by 11.59pm on Friday, 4th December.
Capital at risk |
   |
|
|
| Received this email from a friend? |
Want money-making insights like this sent straight to your inbox every day? Click the button below to join Exponential Investor.
Plus, you'll get our latest FREE report "3 Buy and Hold Stocks for 2020" immediately.
|
|
|
|
| My thoughts on the vaccine |
In today's Exponential Investor… How can we think more deeply about the vaccine? Three reasons why the speed of it shouldn't concern you What I'd like to do before getting it myself The news today is that the UK will see vaccinations beginning from as early as next week. Will you take…
|
|
| Ever had a $40,000 olive? |
In today's Exponential Investor… Please summer, come back to us! Ultimate corporate weight loss ,000 olives and 0,000 limes As I look outside the window today I find myself somewhat daydreaming of the summer to come next year. I will be the first to admit, 2020 has been a big…
|
|
Although Southbank Investment Research Ltd, the publisher of Exponential Investor, is regulated by the Financial Conduct Authority, the editorial content in Exponential Investor is not regulated by the Financial Conduct Authority.
The editorial content is for general information only; it gives no advice on investments and is not intended to be relied upon by individual readers in making (or not making) specific investment decisions. Appropriate independent advice should be obtained before making any such decision.
From time to time we may tell you about other information services published by Southbank Investment Research Limited which do contain content which is regulated by the FCA. When viewing that regulated content, you should review the risk warnings accompanying it.
Email Reference: EXIED01
ISSN 2398-7189.
Contact Us
To contact customer services, please click here. Alternatively, telephone us on 0203 966 4580, Monday to Friday, 9.00am - 5.30pm. Full details of our complaints procedure and terms and conditions can be found on our website, www.southbankresearch.com.
To unsubscribe from Exponential Investor please click here
© 2020 Southbank Investment Research Ltd. Registered in England and Wales No 9539630. VAT No GB629 7287 94. Registered Office: 2nd Floor, Crowne House, 56-58 Southwark Street, London, SE1 1UN. Authorised and regulated by the Financial Conduct Authority. FRN 706697.
|
Tidak ada komentar:
Posting Komentar